Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Bungkwn Lee
Bungkwn Lee was appointed in a total of 2 companies and resigned from 1 of these appointments.
Role
Director
Country Of Residence
South Korea
Nationality
South Korean
Date of Birth
April 1960
Occupations
Unreported • Professional Investor
Active
1
Resigned
1
Dissolved
0
Other
0
Total
2
Companies
Company
Timeline
Status
Oxford Cancer Biomarkers Limited
Director • Unreported
10 Sep 2019
←
6 Years
→
Current
Active
Argonaut Therapeutics Limited
Director • Professional Investor
21 Dec 2018
←
3 Years
→
26 Sep 2022
Active
Mutual People
Prof Nicholas Barrie La Thangue
Argonaut Therapeutics Limited
and
Oxford Cancer Biomarkers Limited
are mutual companies.
Prof David James Kerr
Oxford Cancer Biomarkers Limited
is a mutual company.
William John Robert Fleming
Argonaut Therapeutics Limited
is a mutual company.
Glyn Owain Edwards
Oxford Cancer Biomarkers Limited
is a mutual company.
Mr Alasdair Macdonald
Oxford Cancer Biomarkers Limited
is a mutual company.
Matthew Gerard Winston Frohn
Oxford Cancer Biomarkers Limited
is a mutual company.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
EXPLORE ENDOLE APP